2023
DOI: 10.1111/fcp.12938
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, spectroscopic characterization, and antibacterial activity of chalcone (2E)‐1‐(3′‐aminophenyl)‐3‐(4‐dimethylaminophenyl)‐prop‐2‐en‐1‐one against multiresistant Staphylococcus aureus carrier of efflux pump mechanisms and β‐lactamase

Abstract: BackgroundThe bacterium Staphylococcus aureus has stood out for presenting a high adaptability, acquiring resistance to multiple drugs. The search for natural or synthetic compounds with antibacterial properties capable of reversing the resistance of S. aureus is the main challenge to be overcome today. Natural products such as chalcones are substances present in the secondary metabolism of plants, presenting important biological activities such as antitumor, antidiabetic, and antimicrobial activity.Objectives… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…Several natural or synthetic compounds have been characterized as efflux pump inhibitors (EPIs), including alkamides [8], terpenoids [9], flavonoids [10,11], chalcones [12][13][14], imidazolidines [15], 1,8-naphthyridines sulfonamides [16], 2-phenylquinoline derivatives [17], pyridine-3-boronic acid derivatives [18], and indole-based derivatives [19], among others. Clinically approved drugs for other clinical indications, such as nilotinib and azelastine, have shown good inhibitory activity against NorA [20].…”
Section: Introductionmentioning
confidence: 99%
“…Several natural or synthetic compounds have been characterized as efflux pump inhibitors (EPIs), including alkamides [8], terpenoids [9], flavonoids [10,11], chalcones [12][13][14], imidazolidines [15], 1,8-naphthyridines sulfonamides [16], 2-phenylquinoline derivatives [17], pyridine-3-boronic acid derivatives [18], and indole-based derivatives [19], among others. Clinically approved drugs for other clinical indications, such as nilotinib and azelastine, have shown good inhibitory activity against NorA [20].…”
Section: Introductionmentioning
confidence: 99%